Danske Invest China vs Swedbank Robur Healthcare

Danske Invest China vs Swedbank Robur Healthcare

1. Danske Invest China

  • Security

    Danske Invest China A

  • Fee

    2.15%

  • ISIN

    LU0178668348

  • Holdings

    6

2. Swedbank Robur Healthcare

  • Security

    Swedbank Robur Healthcare A

  • Fee

    1.30%

  • ISIN

    SE0000639445

  • Holdings

    25

Fund Holdings

We have information about 9 holdings in Danske Invest China, where the largest holding is BYD (2.56), followed by NetEase ADR (2.36) and JD.com (1.47). In comparison with Swedbank Robur Healthcare, we have 28 holdings where UnitedHealth is the largest holding (8.49), followed by Eli Lilly (8.12) and AstraZeneca (6.21).

All Holdings

Here we compare the holdings in Danske Invest China and Swedbank Robur Healthcare.

Danske Invest China Swedbank Robur Healthcare
1. BYD Co Ltd Class H
China
2.56 %
1. UnitedHealth Group Inc
USA
8.49 %
2. NetEase ADR
China
2.36 %
2. Eli Lilly and Co
USA
8.12 %
3. JD.com Inc
China
1.47 %
3. AstraZeneca
Sweden UK
6.21 %
4. Xpeng Inc
1.27 %
4. Novo Nordisk B
Denmark
5.78 %
5. Industrial and Commercial Bank of China Ltd Class H
China
1.25 %
5. AbbVie Inc
USA
5.01 %
6. Wuxi AppTec Co Ltd
China
1.01 %
6. Merck & Co Inc
Germany
4.71 %
- 7. Thermo Fisher Scientific Inc
4.45 %
- 8. McKesson Corp
USA
4.27 %
- 9. Abbott Laboratories
USA
4.24 %
- 10. Danaher Corp
USA
4.03 %
- 11. Roche Holding AG
Switzerland
3.84 %
- 12. Boston Scientific Corp
3.73 %
- 13. Centene Corp
3.56 %
- 14. Vertex Pharmaceuticals Inc
3.28 %
- 15. Sanofi SA
France
2.96 %
- 16. HCA Healthcare Inc
2.76 %
- 17. Merck KGaA
Germany
2.19 %
- 18. Cooper Companies Inc
1.78 %
- 19. Edwards Lifesciences Corp
1.62 %
- 20. Takeda Pharmaceutical Co Ltd
Japan
1.55 %
- 21. Hologic Inc
1.43 %
- 22. IQVIA Inc
1.36 %
- 23. Royalty Pharma Plc
1.36 %
- 24. Halozyme Therapeutics Inc
0.91 %
- 25. ConvaTec Group Plc
0.83 %

The list of fund holdings was last updated on April 18, 2025.